Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-09-09

Clinical Trial Update: Aspirin and Renal Disease Progression in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update examining aspirin's effect on renal disease progression in patients with type 2 diabetes. No results or status details are provi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Diabetes | Phase 3 | Status: UNKNOWN